Sri Lanka | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2011 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Sri Lanka totalled $ 12.1 million in 2023. Sales of commodity group 30 from Sri Lanka went up by 1.98% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 237 thousand (cumulative exports of commodity group 30 from Sri Lanka amounted $11.9 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.1% of total exports from Sri Lanka (cumulative merchandise exports from Sri Lanka totalled $ 12 billion in 2023). The share of commodity group 30 in total exports from Sri Lanka increased by 0.013 p.p. compared to 2022 (it was 0.087% in 2022 and cumulative exports from Sri Lanka were equal to $ 13.5 billion).
Where does Sri Lanka export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Sri Lanka in 2023:
- Maldives with a share of 27% (3.39 million US$)
- India with a share of 22% (2.7 million US$)
- Kenya with a share of 17% (2.07 million US$)
- Japan with a share of 8.23% (1 million US$)
- United Arab Emirates with a share of 5.66% (688 thousand US$)
- Russia with a share of 2.65% (322 thousand US$)
- Pakistan with a share of 2.24% (273 thousand US$)
- Georgia with a share of 2.1% (255 thousand US$)
- United Kingdom with a share of 1.43% (175 thousand US$)
- Australia with a share of 1.19% (144 thousand US$)
Exports structure of 30 - Pharmaceutical products - from Sri Lanka in 2023 represented by the following main commodity groups:
- 73% (8.94 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 14.7% (1.79 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 7.75% (943 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 2.42% (295 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.54% (187 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.001% (175 US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Sri Lanka totalled $ 562 million in 2023. Sales of commodity group 30 to Sri Lanka went up by 25% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 114 million (the value of imports of commodity group 30 to Sri Lanka was equal to $448 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.43% of total import flow to Sri Lanka (in 2023, total imports to Sri Lanka amounted to $ 16.3 billion). The share of commodity group 30 in total imports to Sri Lanka increased by 0.881 p.p. compared to 2022 (it was 2.55% in 2022 and cumulative imports to Sri Lanka were equal to $ 17.5 billion).
Where does Sri Lanka import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Sri Lanka in 2023:
- India with a share of 50% (282 million US$)
- USA with a share of 16.2% (91 million US$)
- Pakistan with a share of 6.06% (34 million US$)
- Bangladesh with a share of 4.67% (26 million US$)
- France with a share of 2.98% (16.8 million US$)
- Indonesia with a share of 2.45% (13.8 million US$)
- China with a share of 1.61% (9.06 million US$)
- United Kingdom with a share of 1.53% (8.63 million US$)
- Germany with a share of 1.38% (7.8 million US$)
- Malaysia with a share of 1.33% (7.5 million US$)
Imports structure of 30 - Pharmaceutical products - to Sri Lanka in 2023 represented by the following main commodity groups:
- 90% (510 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 5.22% (29 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.09% (11.8 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.35% (7.64 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.563% (3.16 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.006% (36 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
